9988.HK (9988.HK)

$2.35T
Market Cap
22.3
P/E Ratio
0.43
Beta
0.80%
Dividend Yield
Piotroski 7/9Altman Z 3.5 SafeBeneish M -2.05 Flag (> −2.22)ROIC−WACC +1.8%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 3.5 (above 3.0 safe zone threshold). Beneish M-Score of -2.05 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company demonstrates a robust fundamental profile characterized by strong profitability drivers and solid financial health. The ROIC-WACC spread of +2.2% indicates value creation, though the margin for error is moderate compared to high-growth peers. DuPont decomposition reveals that an 11.9% return on equity is primarily fueled by exceptional net margins at 13.1%, supported by a healthy gross margin of 40.0%, rather than aggressive leverage or asset turnover which sits at 0.55x. This operational stability is corroborated by high-quality integrity metrics: a Piotroski F-Score of 7/9 signals strong financial position and profitability trends, while an Altman Z-Score of 3.5 places the firm in the "Safe Zone" regarding bankruptcy risk. Additionally, a Beneish M-Score of -2.05 suggests earnings are unlikely to be manipulated, reinforcing confidence in the reported net margins.

Valuation currently sits at a premium relative to historical norms and sector averages, trading at 22.3x forward earnings. While the DCF model implies a fair value of $124 based on current inputs, this multiple assumes sustained execution aligned with the modest yet steady revenue growth trajectory of 5.9% year-over-year. The market appears pricing in continued margin expansion given the high net profit conversion, but the elevated P/E suggests limited room for error if top-line acceleration fails to materialize beyond the single-digit growth rate observed recently.

Insider flow over the last ninety days remains neutral with zero activity, offering no clear directional signal from management regarding capital allocation or confidence levels in near-term prospects. The convergence of strong quality scores and elevated valuation creates a scenario where downside protection is provided by fundamental durability, yet upside potential may be capped until growth rates accelerate to justify the current multiple expansion.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.7%9.7%
2%$139$96$70
3%$181$114$78
4%$264$141$90

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.7%, terminal growth 3%. Fair value $114 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
3.5
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.05
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

40.0%
Gross Margin
13.1%
Net Margin
9.5%
ROIC
7.7%
WACC
ROIC − WACC Spread: +1.8%— Positive spread.
+5.9%
Revenue Growth (YoY)
+62.6%
Earnings Growth (YoY)
77.5B
Free Cash Flow
38%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

13.1%
Net Profit Margin
NI ÷ Revenue
×
0.55x
Asset Turnover
Revenue ÷ Assets
×
1.66x
Equity Multiplier
Assets ÷ Equity
=
11.9%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

0.66x
Debt / Equity
1.55x
Current Ratio
17.2x
Interest Coverage
0.3x
Net Debt / EBITDA
3.21%
FCF Yield
207.5B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.53
Act: $1.57
+2.5%
Q3
✗ Miss
Est: $1.88
Act: $1.84
-1.9%
Q2
✗ Miss
Est: $0.73
Act: $0.55
-25.1%
Q1
✗ Miss
Est: $1.39
Act: $0.89
-35.9%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

15.5
Forward P/E
PEG Ratio
0.24
Price/Book
88M
Avg Volume
$186.20
52W High
$95.70
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$3.4B
Tracked Passive Exposure
2
ETFs Holding 9988.HK
2.44%
Avg Weight in ETFs
$141B
Total ETF AUM

When investors buy or sell ETFs like MCHI or IEMG, the fund manager is mechanically forced to buy or sell 9988.HK shares regardless of 9988.HK's individual fundamentals. We estimate $3.4B of passive capital is structurally linked to 9988.HK through 2 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in 9988.HK to visualize passive redemption contagion across ETFs and collateral stocks.

9988.HK Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
9988.HKEpicenterIEMGETFMCHIETF0700.HKLow Risk2330.TWLow Risk005930.KSUnknown00939Unknown000660.KSUnknown
9988.HK Price Drop (%)0

If 9988.HK (9988.HK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Tencent Holdings Ltd (0700.HK) as the most exposed collateral stock, sharing 2 ETFs with 9988.HK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

9988.HK Ownership Dynamics

Ticker
9988.HK

ETFs with Highest 9988.HK Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

9988.HK Capital Efficiency

How efficiently does 9988.HK convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$77.5B
EBITDA
$207.5B
FCF Conversion
37%
Reinvestment Rate
63%
37% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
9.5%
ROIC − WACC Spread
1.9%

9988.HK converts 37% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 63% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 1.9% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare 9988.HK to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.